Trial intelligence / Profile preview

Effect of tacrolimus ointment on patch test responses in nickel sensitivity

2005-000606-31Phase 4Completed

Sponsor
NHS Lothian
Start
May 2005
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of Envarsus XR in contact hypersensitivity and nickel allergy (2 arms), sponsored by NHS Lothian. Started May 2005; status: completed.

02

Drugs

Envarsus XR
03

Conditions

contact hypersensitivitynickel allergy

Beyond the preview

Go deeper on 2005-000606-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-000606-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call